Keros Therapeutics (KROS) Stock Chart & Stock Price History $10.79 -0.20 (-1.82%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$10.80 +0.01 (+0.05%) As of 03/28/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Keros Therapeutics Stock Price Performance 5 Day Performance-4.43%1 Month Performance-2.62%3 Month Performance-31.01%6 Month Performance-81.42%Year-To-Date Performance-31.84%1 Year Performance-83.70% Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address KROS Stock Chart for Sunday, March, 30, 2025 KROS Chart by TradingViewRemove Ads Keros Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2025$10.99$10.79-1.82%$10.97$10.59277,817 shs$437.66 million03/27/2025$11.01$10.99-0.18%$11.10$10.84332,431 shs$445.78 million03/26/2025$11.29$11.01-2.48%$11.36$10.84493,307 shs$446.59 million03/25/2025$11.44$11.29-1.31%$11.46$11.12428,232 shs$457.95 million03/24/2025$11.22$11.44+1.96%$11.63$11.29401,025 shs$464.03 million03/21/2025$11.44$11.22-1.92%$11.51$11.181.33 million shs$455.11 million03/20/2025$11.42$11.44+0.18%$11.55$11.26323,260 shs$464.03 million03/19/2025$11.35$11.42+0.62%$11.61$11.19507,801 shs$463.22 million03/18/2025$11.62$11.35-2.32%$11.57$11.26678,562 shs$460.38 million03/17/2025$11.58$11.62+0.35%$11.74$11.26656,441 shs$471.33 million Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/14/2025$11.47$11.58+0.96%$11.77$11.52374,066 shs$469.71 million03/13/2025$11.76$11.47-2.47%$11.94$11.32371,376 shs$465.25 million03/12/2025$11.51$11.76+2.17%$11.89$11.42553,024 shs$477.01 million03/11/2025$10.91$11.51+5.50%$11.52$10.62876,463 shs$466.87 million03/10/2025$11.38$10.91-4.13%$11.36$10.74982,078 shs$442.53 million03/07/2025$11.93$11.38-4.61%$12.04$11.311.08 million shs$461.60 million03/06/2025$11.67$11.93+2.23%$12.28$11.37826,079 shs$483.91 million03/05/2025$11.59$11.67+0.69%$11.80$11.22835,812 shs$473.36 million03/04/2025$11.10$11.59+4.41%$11.73$10.801.23 million shs$469.48 million03/03/2025$11.08$11.10+0.18%$11.37$11.031.06 million shs$449.63 million02/28/2025$11.01$11.08+0.64%$11.11$10.632.03 million shs$448.82 million Related Companies Disc Medicine Stock Price Chart Agios Pharmaceuticals Stock Price Chart Apogee Therapeutics Stock Price Chart Mesoblast Stock Price Chart Vera Therapeutics Stock Price Chart Galapagos Stock Price Chart Kiniksa Pharmaceuticals Stock Price Chart Schrödinger Stock Price Chart Ascentage Pharma Group International Stock Price Chart IDEAYA Biosciences Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KROS Stock Free KROS Stock Alerts